Faculty conversation: TQT study – this is the end!

Recently, the FDA, other regulatory bodies, and pharmaceutical companies have been exploring options to replace TQTs with preclinical testing or with data collected during standard Phase I trials.

Join colleagues from the FPM and also the British Pharmacological Society and Association for Human Pharmacology in the Pharmaceutical Industry to debate the current scientific, regulatory and safety issues around TQT studies and potential alternatives.

Click here for further information or visit the Faculty of Pharmaceutical Medicine website to register.

0 Comments Add Your Comments

EUFEMED Joint Conference of European Human Pharmacological Societies 2015

The European Federation for Exploratory Medicines Development (EUFEMED), a newly formed Federation of Early Phase associations; Club Phase 1 (France), BAPU (Belgium), AGAH (Germany) and AHPPI (UK), proudly hosted the 3rd Joint Conference of European Human Pharmacological Societies, which took place 21st and 22nd May 2015 in Brussels.

Delivered by an excellent panel of key industry representatives, the meeting provided an overview on Europe’s current global market position, advances in European clinical trial regulation and current issues in exploratory clinical drug development, attracting a wide audience of scientific, regulatory and academic professionals across Europe.

Download speaker presentations

0 Comments Add Your Comments

EUFEMED consultation response to EMA Draft proposal for an addendum, on transparency, to the ‘functional specifications for the European Union (EU) portal and EU database to be audited’

The EMA recently launched a public consultation on their “Draft proposal for an addendum, on transparency, to the “Functional specifications for the EU portal and EU database to be audited – EMA/42176/2014”, for proposals and options on the application of exceptions in relation to the transparency provisions of the European Clinical Trial Regulation.

Following the review of the EMA’s proposals, the AHPPI have submitted a joint response to the consultation together with all associations incorporated into the European Federation for Exploratory Medicines Development (EUFEMED).

Click here to download the response

AHPPI committee members actively participate in the ongoing discussions and stakeholder meetings on a European and UK level. Any additional feedback and support from our members is most welcome.

0 Comments Add Your Comments

EUFEMED – Joint Conference of European Human Pharmacological Societies 2015

Hosted by the Belgian Association of Phase I Units (BAPU) and organised in collaboration with the European early clinical drug development associations from France (Club Phase 1), Germany (AGAH) and the United Kingdom (AHPPI), EUFEMED welcomes you to attend the 3rd Joint Conference of European Human Pharmacological Societies, taking place 21-22 May 2015 in Brussels, in celebration of its foundation.

The meeting will assess the competitiveness of Europe in early clinical drug development, the impact of the new European regulation as well as the challenges encountered in conducting exploratory clinical studies in a continuously changing environment.

For further information and to regsiter vist the EUFEMED website: www.eufemed.eu

0 Comments Add Your Comments



Academy of Medical Sciences, London,

Thursday 30th October 2014.

We are pleased to announce that AHPPI members are invited to speak at this year’s conference. In contrast to previous years, the meeting will be divided into two parts; the first part being a selection of ten-minute presentations by our members and the latter part a dynamic discussion to guide the future of the AHPPI.

Further information can be found here..

0 Comments Add Your Comments


Thursday October 30th

13.30 – 17.30

Academy of Medical Sciences, London.

Further details to follow soon.

0 Comments Add Your Comments

Introductory Course on Human Pharmacology / Translational Medicine – Part II, Heidelberg (Germany), 13th – 15th February 2014

The AGAH board invite new and existing participants to the continuation of the November 2013 workshop.  This course provides a basic training in Human Pharmacology and is addressed to postgraduates in life sciences interested in early clinical development of medicinal products.  The program, further details and the online form can be found here,

0 Comments Add Your Comments

Club Phase 1 invite AHPPI members to 4th February meeting

Predictive Toxicology and Clinical Pharmacology, Paris (France), 4th February 2014

Our colleagues at Club Phase 1 invite AHPPI members to their upcoming annual meeting.  Interested parties should register no later than 25th January 2014. Further details can be found here.


0 Comments Add Your Comments

AVAILABLE NOW: 2013 AHPPI Conference Presentations

Translational PD Studies in Early Stage CNS Drug Development

24th October 2013 at Academy of Medical Sciences

This year’s AHPPI event was highly successful and well attended. It has been praised by delegates for the high quality of information and informative presentations.  We’d like to thank our highly acclaimed speakers, our sponsors and of course the delegates for their part in making the afternoon so enjoyable. Click here to view the presentations.

0 Comments Add Your Comments

BPS invite AHPPI members to Pharmacology 2013


On behalf of the British Pharmacological Society, we are delighted to invite AHPPI members to register for Pharmacology 2013, which will be held on 17–19 December at the Queen Elizabeth II (QEII) Conference Centre, London, UK. Formerly known as the BPS Winter Meeting, Pharmacology 2013 reaffirms our commitment to ‘Today’s science, tomorrow’s medicines’ by providing the highest quality scientific content and invaluable networking opportunities for attendees from the UK and overseas.

AHPPI members can register from £125 per day or £295 for three days – simply login to the registration website. BPS members are eligible for FREE registration through the BPS members’ area and it is usually less expensive to join the Society than to pay non-member registration fees. For information on membership, please email Paul Tizard at the BPS office.

Why register for Pharmacology 2013?

  • BPS will be opening up this year’s meeting to a greater number of attendees than ever before, as we decided to move to a new, larger space within the QEII Conference Centre
  • High quality sessions and expert speakers are already confirmed in the scientific programme, with nine symposia covering the whole spectrum of pharmacology including a session devoted to the Drug Discovery of the Year
  • Poster and oral presentations are a key component of the meeting, and you are warmly invited to submit your abstract by Monday 16 September 2013
  • Networking opportunities continue to be a focus, so remember to book your place at the Welcome Reception and Annual Dinner & Prize-Giving when you register

Don’t take our word for it!

In our 2012 Meetings Survey, 92% of respondents rated the scientific content of BPS meetings as high quality and 90% agreed that they would recommend BPS meetings to their colleagues. To find out more, watch our video with highlights from last year’s meeting.

We look forward to you joining us in London and hope you will share the details of this meeting with your colleagues. If you have any queries or need further information, please contact the BPS Meetings team on meetings@bps.ac.uk or call +44 (0)20 7239 0176.

Best wishes,

Professor Phil Routledge, BPS President


Professor David Webb, BPS Vice President – Meetings

0 Comments Add Your Comments